NovoTTF System for Glioblastoma Tumors

by Savitha C Muppala on  March 20, 2011 at 12:54 PM Medical Gadgets   - G J E 4
NovoTTF system for glioblastoma tumors is capable of giving electric currents to disrupt tumor cells before they divide. FDA is yet to give the final approval for its use on patients with glioblastoma tumors.
 NovoTTF System for Glioblastoma Tumors
NovoTTF System for Glioblastoma Tumors

U.S. Food and Drug Administration (FDA) Neurological Devices Advisory Panel is of the opinion that the risks of using the NovoTTF-100A System (NovoTTF) is reduced when it is administered as monotherapy instead of standard medical therapy.

A randomized phase III trial for 237 patients with glioblastoma tumors showed that patients treated with the NovoTTF were benefited with better survival time than patients treated with chemotherapy. NovoTTF treated patients also said that they had better quality of life and lesser side effects compared to those treated with chemo.

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
it's good that they have found a new safer and better treatment for glioblastoma.
ennairam_23 Sunday, March 20, 2011

You May Also Like

View All

More News on: